Cargando…
The future exacerbation and mortality of different inhalation therapies among patients with chronic obstructive pulmonary disease in various GOLD groups: a focus on the GOLD 2017 and GOLD 2023 reports
BACKGROUND: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report revised the combined assessment, merged the C and D groups into the E group, and revised the initial inhalation therapy recommendation. OBJECTIVES: This study aimed to analyze the future exacerbation and mortal...
Autores principales: | Song, Qing, Cheng, Wei, Liu, Cong, Li, Xueshan, Lin, Ling, Peng, Yating, Zeng, Yuqin, Yi, Rong, Liu, Yi, Li, Xin, Chen, Yan, Cai, Shan, Chen, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685753/ https://www.ncbi.nlm.nih.gov/pubmed/38018090 http://dx.doi.org/10.1177/17534666231213715 |
Ejemplares similares
-
GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
por: Agustí, Alvar, et al.
Publicado: (2023) -
The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients
por: Song, Qing, et al.
Publicado: (2021) -
Exploring the Validity of GOLD 2023 Guidelines: Should GOLD C and D Be Combined?
por: Duckworth, Christopher, et al.
Publicado: (2023) -
Gold 2023: Highlights for primary care
por: Agustí, Alvar, et al.
Publicado: (2023) -
The Impact of the GOLD 2023 on Clinical Treatment in Northeast China
por: Zhou, Jiawei, et al.
Publicado: (2023)